Free Trial
NYSEAMERICAN:CCEL

Cryo-Cell International (CCEL) Stock Price, News & Analysis

Cryo-Cell International logo
$4.91 +0.16 (+3.37%)
Closing price 04:10 PM Eastern
Extended Trading
$4.93 +0.02 (+0.41%)
As of 05:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cryo-Cell International Stock (NYSEAMERICAN:CCEL)

Key Stats

Today's Range
$4.80
$5.25
50-Day Range
$4.80
$5.48
52-Week Range
$4.75
$9.43
Volume
16,903 shs
Average Volume
13,274 shs
Market Capitalization
$39.67 million
P/E Ratio
491.49
Dividend Yield
12.22%
Price Target
$8.50
Consensus Rating
Buy

Company Overview

Cryo-Cell International Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

CCEL MarketRank™: 

Cryo-Cell International scored higher than 53% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cryo-Cell International is 491.49, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.60.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cryo-Cell International is 491.49, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.57.

  • Percentage of Shares Shorted

    0.20% of the float of Cryo-Cell International has been sold short.
  • Short Interest Ratio / Days to Cover

    Cryo-Cell International has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cryo-Cell International has recently increased by 8.11%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    Cryo-Cell International is a leading dividend payer. It pays a dividend yield of 12.50%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Cryo-Cell International does not have a long track record of dividend growth.

  • Read more about Cryo-Cell International's dividend.
  • Percentage of Shares Shorted

    0.20% of the float of Cryo-Cell International has been sold short.
  • Short Interest Ratio / Days to Cover

    Cryo-Cell International has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Cryo-Cell International has recently increased by 8.11%, indicating that investor sentiment is decreasing significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, Cryo-Cell International insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      36.86% of the stock of Cryo-Cell International is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Only 10.44% of the stock of Cryo-Cell International is held by institutions.

    • Read more about Cryo-Cell International's insider trading history.
    Receive CCEL Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Cryo-Cell International and its competitors with MarketBeat's FREE daily newsletter.

    CCEL Stock News Headlines

    CCEL Cryo-Cell International, Inc. - Seeking Alpha
    Banks aren’t ready for this altcoin—are you?
    The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket change.
    Cryo-Cell price target lowered to $8.50 from $9 at Maxim
    See More Headlines

    CCEL Stock Analysis - Frequently Asked Questions

    Cryo-Cell International's stock was trading at $6.50 at the start of the year. Since then, CCEL shares have decreased by 24.5% and is now trading at $4.91.

    Cryo-Cell International Inc. (NYSEAMERICAN:CCEL) released its quarterly earnings data on Tuesday, October, 15th. The company reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.11. The firm earned $8.07 million during the quarter. Cryo-Cell International had a net margin of 0.40% and a negative trailing twelve-month return on equity of 1.07%.

    Shares of CCEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that Cryo-Cell International investors own include Meta Platforms (META), Alimera Sciences (ALIM), Crescent Biopharma (CBIO), iClick Interactive Asia Group (ICLK), NVIDIA (NVDA), AcelRx Pharmaceuticals (ACRX) and Aspen Group (ASPU).

    Company Calendar

    Last Earnings
    10/15/2024
    Record date for 5/30 Dividend
    5/21/2025
    Dividend Payable
    5/30/2025
    Today
    7/15/2025
    Fiscal Year End
    11/30/2025

    Industry, Sector and Symbol

    Stock Exchange
    NYSEAMERICAN
    Sector
    Medical
    Industry
    Medical Services
    Sub-Industry
    Healthcare
    Current Symbol
    NYSEAMERICAN:CCEL
    CIK
    862692
    Employees
    90
    Year Founded
    N/A

    Price Target and Rating

    High Price Target
    $8.50
    Low Price Target
    $8.50
    Potential Upside/Downside
    +78.9%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    1 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($1.06)
    Trailing P/E Ratio
    475.48
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    $400 thousand
    Net Margins
    0.40%
    Pretax Margin
    7.92%
    Return on Equity
    -1.07%
    Return on Assets
    0.20%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    0.58
    Quick Ratio
    0.54

    Sales & Book Value

    Annual Sales
    $31.99 million
    Price / Sales
    1.20
    Cash Flow
    $0.18 per share
    Price / Cash Flow
    26.78
    Book Value
    ($1.64) per share
    Price / Book
    -2.90

    Miscellaneous

    Outstanding Shares
    8,080,000
    Free Float
    5,103,000
    Market Cap
    $38.38 million
    Optionable
    Not Optionable
    Beta
    0.64

    Social Links

    Beginner's Guide To Retirement Stocks Cover

    Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

    Get This Free Report

    This page (NYSEAMERICAN:CCEL) was last updated on 7/15/2025 by MarketBeat.com Staff
    From Our Partners